mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0005 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.01 |
mRNA |
temsirolimus |
FIMM |
pan-cancer |
AAC |
0.26 |
0.1 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.5 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.2 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
0.04 |
0.5 |
mRNA |
thapsigargin |
GDSC1000 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.3 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |